A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response
- PMID: 11861495
- DOI: 10.1210/endo.143.3.8664
A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response
Abstract
High doses of GH, used to induce anabolism in prolonged critically ill patients, unexpectedly increased mortality. To further explore underlying mechanisms, a valid animal model is needed. Such a model is presented in this study. Seven days after arterial and venous cannulae placement, male New Zealand White rabbits were randomly allocated to a control or a critically ill group. To induce prolonged critical illness, a template controlled 15% deep dermal burn injury was imposed under combined general and regional (paravertebral) anesthesia. Subsequently, critically ill rabbits received supplemental analgesia and were parenterally fed with glucose, insulin, amino acids, and lipids. On d 1 and d 8 after randomization, acute and chronic spontaneous hormonal profiles of GH, TSH, and PRL secretion were obtained by sampling blood every 15 min for 7 h. Furthermore, GH, TSH, and PRL responses to an iv bolus of GH-releasing peptide 2 (GHRP-2) + TRH were documented on d 0, 1, and 8. Hemodynamic status and biochemical parameters were evaluated on d 0, 1, 3, 5, and 8, after which animals were killed and relative wet weight and water content of organs was determined. Compared with controls, critically ill animals exhibited transient metabolic acidosis on d 1 and weight loss, organ wasting, systolic hypertension, and pronounced anemia on d 8. On d 1, pulsatile GH secretion doubled in the critically ill animals compared with controls, and decreased again on d 8 in the presence of low plasma IGF-I concentrations from d 1 to d 8. GH responses to GHRP-2 + TRH were elevated on d 1 and increased further on d 8 in the critically ill animals. Mean TSH concentrations were identical in both groups on d 1 and 8, in the face of dramatically suppressed plasma T(4) and T(3) concentrations in the critically ill animals. PRL secretion was impaired in the critically ill animals exclusively on d 8. TSH and PRL responses to GHRP-2 and TRH were increased only on d 1. In conclusion, this rabbit model of acute and prolonged critical illness reveals several of the clinical, biochemical, and endocrine manifestations of the human counterpart.
Similar articles
-
Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness.Endocrinology. 2004 Jan;145(1):205-13. doi: 10.1210/en.2003-1005. Epub 2003 Oct 9. Endocrinology. 2004. PMID: 14551231
-
Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.Clin Endocrinol (Oxf). 1997 Nov;47(5):599-612. doi: 10.1046/j.1365-2265.1997.3371118.x. Clin Endocrinol (Oxf). 1997. PMID: 9425400 Clinical Trial.
-
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.Clin Endocrinol (Oxf). 2002 May;56(5):655-69. doi: 10.1046/j.1365-2265.2002.01255.x. Clin Endocrinol (Oxf). 2002. PMID: 12030918 Clinical Trial.
-
Endocrinology in intensive care medicine: new insights and therapeutic consequences.Verh K Acad Geneeskd Belg. 2002;64(3):167-87; discussion 187-8. Verh K Acad Geneeskd Belg. 2002. PMID: 12238241 Review.
-
Novel insights into the neuroendocrinology of critical illness.Eur J Endocrinol. 2000 Jul;143(1):1-13. doi: 10.1530/eje.0.1430001. Eur J Endocrinol. 2000. PMID: 10870025 Review.
Cited by
-
Abdominal Ectopic Pregnancy and Impaired Postnatal Mammary Gland Development, Consistent With Physiologic Agalactia, in a Wild European Rabbit, Oryctolagus cuniculus.Front Vet Sci. 2019 Aug 7;6:254. doi: 10.3389/fvets.2019.00254. eCollection 2019. Front Vet Sci. 2019. PMID: 31440520 Free PMC article.
-
Critical illness-induced bone loss is related to deficient autophagy and histone hypomethylation.Intensive Care Med Exp. 2015 Dec;3(1):52. doi: 10.1186/s40635-015-0052-3. Epub 2015 Jun 21. Intensive Care Med Exp. 2015. PMID: 26215816 Free PMC article.
-
Intensive insulin therapy protects the endothelium of critically ill patients.J Clin Invest. 2005 Aug;115(8):2277-86. doi: 10.1172/JCI25385. J Clin Invest. 2005. PMID: 16075063 Free PMC article. Clinical Trial.
-
Interleukin-2 Transiently Inhibits Pulsatile Growth Hormone Secretion in Young but not Older Healthy Men.J Clin Endocrinol Metab. 2021 Sep 27;106(10):2855-2864. doi: 10.1210/clinem/dgab484. J Clin Endocrinol Metab. 2021. PMID: 34212195 Free PMC article. Clinical Trial.
-
How does blood glucose control with insulin save lives in intensive care?J Clin Invest. 2004 Nov;114(9):1187-95. doi: 10.1172/JCI23506. J Clin Invest. 2004. PMID: 15520847 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources